Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

X0202 SCHEDULE 13D/A 0000899140-25-000768 0002069986 XXXXXXXX LIVE 7 Common 07/07/2026 false 0001802974 60510V108 Mission Produce, Inc. 2710 Camino Del Sol Oxnard CA 93030 Jose Bouzas 507 380 7074 BICSA Financial Center, Piso 39 Panama City R1 0801 0002069986 N Globalharvest Holdings Venture Ltd AF D8 12370439 0 12370439 0 12370439 N 14.01 OO Common Mission Produce, Inc. 2710 Camino Del Sol Oxnard CA 93030 Jose Bouzas BICSA Financial Center, Piso 39, Panama City, Panama 0801 Item 3 is hereby amended and restated as follows: The Reporting Person originally acquired 4,458,750 shares of Common Stock for an aggregate price of $50,234,059.90. The Reporting Person subsequently acquired an additional (i) 842,220 shares of Common Stock for an aggregate price of $10,515,375.32, (ii) 1,021,178 shares of Common Stock for an aggregate price of $12,481,982.74, (iii) 842,095 shares of Common Stock for an aggregate price of $10,057,851.35, (iv) 1,673,043 shares of Common Stock for an aggregate price of $19,619,597.35, (v) 933,322 shares of Common Stock for an aggregate price of $11,817,870.67 using working capital from affiliates of the Reporting Person, (vi) 220,969 shares of Common Stock for an aggregate price of $2,628,524.51, (vii) 549,360 shares of Common Stock received in exchange for 561,145 shares of Calavo Growers, Inc. ("Calavo") common stock in connection with the consummation of the previously announced transaction between the Issuer and Calavo (the "Transaction") (the Reporting Person originally acquired such shares of Calavo common stock for an aggregate purchase price of $14,931,161.09); and (viii) 1,829,502 of Common Stock for an aggregate price of $24,096,808.38. (a) The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the issuer or any of its subsidiaries; (d) Any change in the present board of directors or management of the issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the issuer; (f) Any other material change in the issuer's business or corporate structure, including but not limited to, if the issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by section 13 of the Investment Company Act of 1940; (g) Changes in the issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person; (h) causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the issuer becoming eligible for termination of registration pursuant to section 12(g)(4) of the Act; or (j) Any action similar to any of those enumerated above. Total shares beneficially owned: 12,370,439 Total shares outstanding as of June 3, 2026: 88,319,807, as reported in the Company's Quarterly Report on Form 10-Q filed with the SEC on June 8, 2026. To the Reporting Persons' knowledge, none of the Covered Persons directly owns any Common Shares. Each of the Covered Persons hereby disclaims beneficial ownership of any Common Shares and the filing of this Schedule 13D shall not be construed as an admission that any such Covered Person is the beneficial owner of any securities covered by this Schedule 13D or that any such Covered Person is a member of a "group" for Section 13(d) purposes. See responses to Items 7, 8, 9 and 10 on the cover pages of this filing, which are incorporated herein by reference. The transactions in the Common Stock by the Reporting Person, and any Covered Person, if applicable, since the most recent filing of Schedule 13D are set forth on Schedule A and are incorporated herein by reference. Globalharvest Holdings Venture Ltd /s/ Jose Bouzas, Director Jose Bouzas, Director 07/09/2026